03/18/2024
6:00 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
3:33 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K/A | |
02/15/2024
3:42 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Wong Vivien (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:43 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
STRATTAN CE RICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:44 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Toig Randall M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:45 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Ostronic Francis Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:46 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Sieger Markus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/15/2024
3:40 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
SHANAHAN WILLIAM S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:41 PM | CONKLING WILLIAM (Reporting)
Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
1:44 PM | ARMISTICE CAPITAL, LLC (Filed by)
Cyclo Therapeutics (Subject)
Cyclo Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
01/22/2024
5:01 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
8:48 PM | Cross Shawn (Reporting)
Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/28/2023
8:50 PM | Cross Shawn (Reporting)
Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
7:25 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
3:15 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
5:01 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
5:02 AM | Cyclo Therapeutics (Subject)
Cyclo Therapeutics, Inc. (Subject)
| Form 425 | |
11/30/2023
3:29 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
3:30 PM | Cyclo Therapeutics (Subject)
Cyclo Therapeutics, Inc. (Subject)
| Form 425 | |
11/30/2023
8:04 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
STRATTAN CE RICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:05 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Sieger Markus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:05 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Toig Randall M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:06 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
SHANAHAN WILLIAM S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:06 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Wong Vivien (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:07 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Ostronic Francis Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:08 AM | CONKLING WILLIAM (Reporting)
Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
11:15 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form EFFECT | |
11/21/2023
8:15 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 424B3 | |
11/20/2023
7:50 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form S-4/A | |
11/14/2023
1:41 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
3:45 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
10/24/2023
3:43 PM | Cyclo Therapeutics (Subject)
Cyclo Therapeutics, Inc. (Subject)
Rafael Holdings, Inc. (Filed by)
| Form SC 13D/A | |
10/23/2023
5:05 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
FINE N SCOTT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
5:06 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
TATE JEFFREY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
5:06 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Sieger Markus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
5:07 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Ostronic Francis Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
5:08 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Rafael Holdings, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/20/2023
1:19 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
10:45 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
10:46 AM | Cyclo Therapeutics (Subject)
Cyclo Therapeutics, Inc. (Subject)
| Form 425 | |
09/21/2023
3:28 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Thousands of investors use this no cost solution | Do you? (Ad) In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve.
Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media. Simply tap here now to subscribe and start getting "Insider Financial Advantage" |
09/21/2023
3:28 PM | Cyclo Therapeutics (Subject)
Cyclo Therapeutics, Inc. (Subject)
| Form 425 | |
08/21/2023
7:00 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
7:00 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Wong Vivien (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/21/2023
7:00 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Wong Vivien (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
2:35 PM | Cyclo Therapeutics (Subject)
Cyclo Therapeutics, Inc. (Subject)
Rafael Holdings, Inc. (Filed by)
| Form SC 13D/A | |
07/31/2023
1:16 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
3:01 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form DEF 14A | |
06/07/2023
7:46 PM | CONKLING WILLIAM (Reporting)
Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
8:22 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2023
7:45 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
STRATTAN CE RICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
3:38 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Ostronic Francis Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
3:38 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Toig Randall M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
3:39 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Sieger Markus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
3:39 PM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
SHANAHAN WILLIAM S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
2:42 PM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2023
10:00 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
TATE JEFFREY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2023
9:27 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Ostronic Francis Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2023
9:27 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
Sieger Markus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2023
9:28 AM | Cyclo Therapeutics (Issuer)
Cyclo Therapeutics, Inc. (Issuer)
FINE N SCOTT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2023
8:24 AM | Cyclo Therapeutics (Filer)
Cyclo Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
